Cargando…

Analysis of exosomal competing endogenous RNA network response to paclitaxel treatment reveals key genes in advanced gastric cancer

BACKGROUND: Exosome is an important component of the tumor immune microenvironment and plays critical role in cancer pathogenesis. The exosome transcriptome of gastric cancer (GC) response to paclitaxel chemotherapy has not been investigated in the past. METHODS: ceRNA microarrays were performed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Jun, Zhang, Guifeng, Li, Deyu, Zhong, Jiangming, Chen, Qiao, Lin, Li, Liu, Zhenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640578/ https://www.ncbi.nlm.nih.gov/pubmed/36387235 http://dx.doi.org/10.3389/fonc.2022.1027748

Ejemplares similares

Oncogenic Role and Prognostic Value of MicroRNA-937-3p in Patients with Breast Cancer
por: Li, Deyu, et al.
Publicado: (2019)

RNA atlas and competing endogenous RNA regulation in tissue-derived exosomes from luminal B and triple-negative breast cancer patients
por: Wang, Ji, et al.
Publicado: (2023)

Identification of Key Circulating Exosomal microRNAs in Gastric Cancer
por: Qian, Xiaoqing, et al.
Publicado: (2021)

Efficacy and safety of fluzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: a multi-center, single-arm prospective phase II clinical study (STAMP study)
por: Li, Deyu, et al.
Publicado: (2023)

Integrated Analysis of a Competing Endogenous RNA Network Revealing a Prognostic Signature for Cervical Cancer
por: Xia, Leilei, et al.
Publicado: (2018)

Flavonoids Inhibit Cancer by Regulating the Competing Endogenous RNA Network
por: Li, Chengshun, et al.
Publicado: (2022)

Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer
por: Xiong, Guangbing, et al.
Publicado: (2021)

Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer
por: Xia, Leilei, et al.
Publicado: (2019)

Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells
por: Gao, Liang, et al.
Publicado: (2020)

The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
por: Schirizzi, Annalisa, et al.
Publicado: (2023)

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer
por: Peng, Mou, et al.
Publicado: (2021)

A Key mRNA-miRNA-lncRNA Competing Endogenous RNA Triple Sub-network Linked to Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zhang, Junjie, et al.
Publicado: (2020)

The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
por: Wang, Jianzheng, et al.
Publicado: (2022)

Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2020)

Competing Endogenous RNA: The Key to Posttranscriptional Regulation
por: Sen, Rituparno, et al.
Publicado: (2014)

5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients
por: Zhang, Min, et al.
Publicado: (2020)

Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction
por: Vieira, Lucas Maciel, et al.
Publicado: (2021)

Corrigendum: Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2021)

Exosomes Promote Pre-Metastatic Niche Formation in Gastric Cancer
por: Gao, Jing, et al.
Publicado: (2021)

Combined Analysis of RNA Sequence and Microarray Data Reveals a Competing Endogenous RNA Network as Novel Prognostic Markers in Malignant Pleural Mesothelioma
por: Duan, Weicheng, et al.
Publicado: (2021)

Evaluation of the Diagnostic Potential of a Plasma Exosomal miRNAs Panel for Gastric Cancer
por: Yang, Jiajia, et al.
Publicado: (2021)

A competing endogenous RNA network reveals key lncRNAs associated with sepsis
por: Guo, Xuan, et al.
Publicado: (2020)

Characterization of Cell Cycle-Related Competing Endogenous RNAs Using Robust Rank Aggregation as Prognostic Biomarker in Lung Adenocarcinoma
por: Yang, Yifei, et al.
Publicado: (2022)

MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages
por: Li, Chaofeng, et al.
Publicado: (2022)

Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study
por: D’Alessandro, Rosalba, et al.
Publicado: (2022)

Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer
por: Song, Wei, et al.
Publicado: (2019)

In silico characterization of competing endogenous RNA network in glioblastoma multiforme with a systems biology approach
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer
por: Zhao, Shen, et al.
Publicado: (2022)

Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study
por: D’Alessandro, Rosalba, et al.
Publicado: (2023)

A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

Proteomic Profiling of Serum Exosomes From Patients With Metastatic Gastric Cancer
por: Ding, Xiao-Qing, et al.
Publicado: (2020)

Comprehensive Roles and Future Perspectives of Exosomes in Peritoneal Metastasis of Gastric Cancer
por: Chen, Xiangliu, et al.
Publicado: (2021)

Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel
por: Li, Xiaocheng, et al.
Publicado: (2022)

Recent advances in the roles of exosomal microRNAs in neuroblastoma
por: Bhavsar, Swapnil Parashram
Publicado: (2023)

Circadian rhythm as a key player in cancer progression as well as a therapeutic target in HER2-positive advanced gastric cancer treatment
por: Wang, Shihao, et al.
Publicado: (2023)

Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in Colon Cancer
por: Huang, Qian-Rong, et al.
Publicado: (2019)

MiR-149-5p: An Important miRNA Regulated by Competing Endogenous RNAs in Diverse Human Cancers
por: Ren, Fu-jia, et al.
Publicado: (2021)

S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study
por: Shi, Yan, et al.
Publicado: (2022)

Role of Exosomal Non-coding RNAs in Gastric Cancer: Biological Functions and Potential Clinical Applications
por: Hu, Feng, et al.
Publicado: (2021)

Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol
por: Vatandoust, Sina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_btoso6o2ka5lms5at5j93aqoes